ScheduledOpen Business Meeting•Jun 17, 2026, 2:00 PM
Business meeting to consider S.1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, S.3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, S.4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, S.2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, S.4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, S.2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, S.3014, to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions, and S.1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product.
430, Dirksen Senate Office Building, 430, Dirksen Senate Office Building
Video
Business meeting to consider S.1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, S.3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, S.4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, S.2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, S.4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, S.2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, S.3014, to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions, and S.1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product.Business meeting to consider S.1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, S.3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, S.4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, S.2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, S.4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, S.2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, S.3014, to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions, and S.1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product.